BUZZ-Street View: New growth drivers show promise to boost Medtronic's revenue

Reuters

Feb 20, 2025

BUZZ-Street View: New growth drivers show promise to boost Medtronic's revenue

** Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by distributors, and said the problems would persist in the current quarter

PLETHORA OF CATALYSTS AT PLAY

** J.P. Morgan ("Neutral", PT: $95) says there are reasons to stay more positive into FY26 with growth in co's diabetes and heart device business, along with contribution from new products which are used for procedures such as renal denervation and pulsed field ablation

** RBC Capital markets ("Outperform", PT: $105) says MDT has "plethora of catalysts at play" including its surgical robot Hugo and expansion in its portfolio for cardiac devices, along with significant opportunity in renal denervation

** UBS ("Neutral", PT: $95) sees potential for continued improvement in diabetes segment

** Citi ("Neutral", PT: $92) says Medtronic is standing on the threshold of several new growth drivers that are starting to gain traction

(Reporting by Siddhi Mahatole)

((Siddhiprabhanjan.mahatole@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2512846454"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2512846454\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2512846454?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-20 00:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2512846454","market":"us","top_or_hot":-1,"title":"BUZZ-Street View: New growth drivers show promise to boost Medtronic's revenue","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Street View: New growth drivers show promise to boost Medtronic's revenue</title></head><body><p>** Medtronic <span>on Tuesday</span> missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by distributors, and said the problems would persist in the current quarter</p><p>PLETHORA OF CATALYSTS AT PLAY</p><p>** J.P. Morgan (\"Neutral\", PT: $95) says there are reasons to stay more positive into FY26 with growth in co's diabetes and heart device business, along with contribution from new products which are used for procedures such as renal denervation and pulsed field ablation</p><p>** RBC Capital markets (\"Outperform\", PT: $105) says MDT has \"plethora of catalysts at play\" including its surgical robot Hugo and expansion in its portfolio for cardiac devices, along with significant opportunity in renal denervation</p><p>** UBS (\"Neutral\", PT: $95) sees potential for continued improvement in diabetes segment</p><p>** Citi (\"Neutral\", PT: $92) says Medtronic is standing on the threshold of several new growth drivers that are starting to gain traction</p><p> (Reporting by Siddhi Mahatole)</p><p> ((Siddhiprabhanjan.mahatole@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Street View: New growth drivers show promise to boost Medtronic's revenue</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Street View: New growth drivers show promise to boost Medtronic's revenue\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-02-20 00:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Street View: New growth drivers show promise to boost Medtronic's revenue</title></head><body><p>** Medtronic <span>on Tuesday</span> missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by distributors, and said the problems would persist in the current quarter</p><p>PLETHORA OF CATALYSTS AT PLAY</p><p>** J.P. Morgan (\"Neutral\", PT: $95) says there are reasons to stay more positive into FY26 with growth in co's diabetes and heart device business, along with contribution from new products which are used for procedures such as renal denervation and pulsed field ablation</p><p>** RBC Capital markets (\"Outperform\", PT: $105) says MDT has \"plethora of catalysts at play\" including its surgical robot Hugo and expansion in its portfolio for cardiac devices, along with significant opportunity in renal denervation</p><p>** UBS (\"Neutral\", PT: $95) sees potential for continued improvement in diabetes segment</p><p>** Citi (\"Neutral\", PT: $92) says Medtronic is standing on the threshold of several new growth drivers that are starting to gain traction</p><p> (Reporting by Siddhi Mahatole)</p><p> ((Siddhiprabhanjan.mahatole@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MDT","symbol_name":"美敦力","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nL3N3PA0SA:1","article_id":"2512846454","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2512846454","pubTimestamp":1739982885,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Street View: New growth drivers show promise to boost Medtronic's revenue** Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devi","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"MDT":"美敦力"},"translate_title":"BUZZ-Street View：新的增长动力有望增加美敦力的收入","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDT":0.9},"content_text":"BUZZ-Street View: New growth drivers show promise to boost Medtronic's revenue** Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by distributors, and said the problems would persist in the current quarterPLETHORA OF CATALYSTS AT PLAY** J.P. Morgan (\"Neutral\", PT: $95) says there are reasons to stay more positive into FY26 with growth in co's diabetes and heart device business, along with contribution from new products which are used for procedures such as renal denervation and pulsed field ablation** RBC Capital markets (\"Outperform\", PT: $105) says MDT has \"plethora of catalysts at play\" including its surgical robot Hugo and expansion in its portfolio for cardiac devices, along with significant opportunity in renal denervation** UBS (\"Neutral\", PT: $95) sees potential for continued improvement in diabetes segment** Citi (\"Neutral\", PT: $92) says Medtronic is standing on the threshold of several new growth drivers that are starting to gain traction (Reporting by Siddhi Mahatole) ((Siddhiprabhanjan.mahatole@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}